Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update

[ad_1] Turnstone Biologics Corp. Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programs Cash position expected to fund operations into…